Categories Earnings, Health Care
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.
- Revenue was $1.03 billion in the September quarter, an increase of 3.8% from $989.2 million last year
- Organic revenue rose 4.1%, driven primarily by the Discovery and Safety Assessment and Research Models and Services businesses
- Third-quarter net income decreased 9.4% annually to $87.4 million; earnings per share were $1.69, down 10.1%
- Adjusted net income increased to $140.5 million or $2.72 per share from $134.7 million or $2.63 per share in Q3 2022
- The management expects revenues to grow between 2.5% and 3.5% in fiscal 2023
- Organic revenue is estimated to increase in the range of 5.5% to $6.5%
- The company is looking for full-year earnings in the range of $7.30 per share to $7.50 per share
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
